SGMO - long -catalyst play

11 בפבר׳

Sangamo Therapeutics Inc is a clinical-stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives using platform technologies in genome editing, gene therapy, gene regulation and cell therapy. The company's product pipeline includes Hemophilia, Central Nervous System, HIV, Lysosomal Storage Disorders, and Hemoglobinopathies.

This is not a financial advice!

Upcoming catalyst on 31st. of March

Keep an eye on 0.65 , 1.10 and 1.70 levels- needs to get broken for a further upmove.

SL under 0.3

TP approx. 2.8

Most info on the chart.

Trade carefully!

13 בפבר׳

הערה

i would say good timing

16 בפבר׳

הערה

fucking nailed it again! feel free to take gains if u want.